Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Asset Utilization Ratio (2024 - 2025)

Historic Asset Utilization Ratio for NewAmsterdam Pharma (NAMS) over the last 2 years, with Q3 2025 value amounting to 0.04.

  • NewAmsterdam Pharma's Asset Utilization Ratio fell 4197.05% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 4197.05%. This contributed to the annual value of 0.08 for FY2024, which is 12032.65% up from last year.
  • Per NewAmsterdam Pharma's latest filing, its Asset Utilization Ratio stood at 0.04 for Q3 2025, which was down 4197.05% from 0.08 recorded in Q2 2025.
  • In the past 5 years, NewAmsterdam Pharma's Asset Utilization Ratio registered a high of 0.08 during Q2 2025, and its lowest value of 0.02 during Q2 2024.